Literature DB >> 27087497

Meta-analysis of erythrocyte polyunsaturated fatty acid biostatus in bipolar disorder.

Robert K McNamara1, Jeffrey A Welge2.   

Abstract

OBJECTIVES: Dietary deficiency in polyunsaturated fatty acids (PUFAs), including the omega-3 fatty acids eicosapentaenoic acid (EPA; 20:5n-3) and docosahexaenoic acid (DHA; 22:6n-3), and excesses in omega-6 fatty acids, including linoleic acid (LA; 18:2n-6) and arachidonic acid (AA; 20:4n-6), may be associated with the pathophysiology of bipolar disorder. In an effort to provide clarification regarding the relationship between PUFA biostatus and bipolar disorder, this meta-analysis investigated studies comparing erythrocyte (red blood cell) membrane PUFA composition in patients with bipolar disorder and healthy controls.
METHODS: A meta-analysis was performed on case-control studies comparing erythrocyte PUFA (EPA, DHA, LA and AA) levels in patients with bipolar I disorder and healthy controls. Standardized effect sizes were calculated and combined using a random effects model.
RESULTS: Six eligible case-control studies comprising n = 118 bipolar I patients and n = 147 healthy controls were included in the analysis. Compared with healthy controls, patients with bipolar I disorder exhibited robust erythrocyte DHA deficits (p = 0.0008) and there was a trend for lower EPA (p = 0.086). There were no significant differences in LA (p = 0.42) or AA (p = 0.64).
CONCLUSIONS: Bipolar I disorder is associated with robust erythrocyte DHA deficits. These findings add to a growing body of evidence implicating omega-3 PUFA deficiency in the pathophysiology of bipolar disorder.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  arachidonic acid; bipolar disorder; omega-3 fatty acids; omega-6 fatty acids

Mesh:

Substances:

Year:  2016        PMID: 27087497      PMCID: PMC4882238          DOI: 10.1111/bdi.12386

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  47 in total

Review 1.  Role of perinatal long-chain omega-3 fatty acids in cortical circuit maturation: Mechanisms and implications for psychopathology.

Authors:  Robert K McNamara; Jennifer J Vannest; Christina J Valentine
Journal:  World J Psychiatry       Date:  2015-03-22

Review 2.  Lithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascade.

Authors:  Stanley I Rapoport
Journal:  ACS Chem Neurosci       Date:  2014-05-15       Impact factor: 4.418

3.  Comparative effects of an acute dose of fish oil on omega-3 fatty acid levels in red blood cells versus plasma: implications for clinical utility.

Authors:  William S Harris; Stephen A Varvel; James V Pottala; G Russell Warnick; Joseph P McConnell
Journal:  J Clin Lipidol       Date:  2013-05-07       Impact factor: 4.766

4.  Increased breath ethane levels in medicated patients with schizophrenia and bipolar disorder are unrelated to erythrocyte omega-3 fatty acid abundance.

Authors:  Brian M Ross; Ross Maxwell; Iain Glen
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-11-27       Impact factor: 5.067

Review 5.  Co-occurrence of bipolar and attention-deficit hyperactivity disorders in children.

Authors:  Manpreet K Singh; Melissa P DelBello; Robert A Kowatch; Stephen M Strakowski
Journal:  Bipolar Disord       Date:  2006-12       Impact factor: 6.744

6.  Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.

Authors:  G Paul Amminger; Miriam R Schäfer; Konstantinos Papageorgiou; Claudia M Klier; Sue M Cotton; Susan M Harrigan; Andrew Mackinnon; Patrick D McGorry; Gregor E Berger
Journal:  Arch Gen Psychiatry       Date:  2010-02

7.  Plasma and red blood cell fatty acids in peroxisomal disorders.

Authors:  A B Moser; D S Jones; G V Raymond; H W Moser
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

Review 8.  Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature.

Authors:  Benjamin I Goldstein; David E Kemp; Joanna K Soczynska; Roger S McIntyre
Journal:  J Clin Psychiatry       Date:  2009-06-02       Impact factor: 4.384

9.  Polyunsaturated fatty acid deficit in patients with bipolar mania.

Authors:  Chih-Chiang Chiu; Shih-Yi Huang; Kuan-Pin Su; Mong-Liang Lu; Ming-Chyi Huang; Chiao-Chicy Chen; Winston W Shen
Journal:  Eur Neuropsychopharmacol       Date:  2003-03       Impact factor: 4.600

10.  Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation: a dose-response randomized controlled trial.

Authors:  Michael R Flock; Ann C Skulas-Ray; William S Harris; Terry D Etherton; Jennifer A Fleming; Penny M Kris-Etherton
Journal:  J Am Heart Assoc       Date:  2013-11-19       Impact factor: 5.501

View more
  17 in total

1.  Effects of Fish Oil Monotherapy on Depression and Prefrontal Neurochemistry in Adolescents at High Risk for Bipolar I Disorder: A 12-Week Placebo-Controlled Proton Magnetic Resonance Spectroscopy Trial.

Authors:  Robert K McNamara; Jeffrey R Strawn; Max J Tallman; Jeffrey A Welge; L Rodrigo Patino; Thomas J Blom; Melissa P DelBello
Journal:  J Child Adolesc Psychopharmacol       Date:  2020-03-11       Impact factor: 2.576

Review 2.  Role of polyunsaturated fatty acids in human brain structure and function across the lifespan: An update on neuroimaging findings.

Authors:  Robert K McNamara; Ruth H Asch; Diana M Lindquist; Robert Krikorian
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2017-05-09       Impact factor: 4.006

Review 3.  Polyunsaturated fatty acids and recurrent mood disorders: Phenomenology, mechanisms, and clinical application.

Authors:  Erik Messamore; Daniel M Almeida; Ronald J Jandacek; Robert K McNamara
Journal:  Prog Lipid Res       Date:  2017-01-06       Impact factor: 16.195

4.  Familial risk for bipolar disorder is not associated with impaired peroxisomal function: Dissociation from docosahexaenoic acid deficits.

Authors:  Robert K McNamara; Ann B Moser; Richard I Jones; Ronald Jandacek; L Rodrigo Patino; Jeffrey R Strawn; Stephen M Strakowski; Melissa P DelBello
Journal:  Psychiatry Res       Date:  2016-10-25       Impact factor: 3.222

5.  Effects of dietary-induced alterations in rat brain docosahexaenoic acid accrual on phospholipid metabolism and mitochondrial bioenergetics: An in vivo31P MRS study.

Authors:  Diana M Lindquist; Ruth H Asch; Jennifer D Schurdak; Robert K McNamara
Journal:  J Psychiatr Res       Date:  2017-08-24       Impact factor: 4.791

6.  Red Blood Cell Omega-3 Fatty Acid Composition and Psychotropic Drug Use in Older Adults: Results from the MAPT Study.

Authors:  A Gallini; A Yrondi; C Cantet; M Poncet; B Vellas; L Schmitt; S Andrieu
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

7.  Glutamate homeostasis in the adult rat prefrontal cortex is altered by cortical docosahexaenoic acid accrual during adolescence: An in vivo1H MRS study.

Authors:  Robert K McNamara; Ruth H Asch; Jennifer D Schurdak; Diana M Lindquist
Journal:  Psychiatry Res Neuroimaging       Date:  2017-10-11       Impact factor: 2.376

8.  Role of Omega-3 Fatty Acids in the Etiology, Treatment, and Prevention of Depression: Current Status and Future Directions.

Authors:  Robert K McNamara
Journal:  J Nutr Intermed Metab       Date:  2016-05-04

Review 9.  [Confusion about the effects of omega-3 fatty acids : Contemplation of study data taking the omega-3 index into consideration].

Authors:  C von Schacky
Journal:  Internist (Berl)       Date:  2019-12       Impact factor: 0.743

10.  Fish oil supplementation alters emotion-generated corticolimbic functional connectivity in depressed adolescents at high-risk for bipolar I disorder: A 12-week placebo-controlled fMRI trial.

Authors:  Robert K McNamara; Wenbin Li; Du Lei; Maxwell J Tallman; Jeffrey A Welge; Jeffrey R Strawn; Luis Rodrigo Patino; Melissa P DelBello
Journal:  Bipolar Disord       Date:  2021-07-23       Impact factor: 6.744

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.